Compare ECOR & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | NVX |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | Australia |
| Employees | N/A | 192 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 95.9M |
| IPO Year | 2018 | N/A |
| Metric | ECOR | NVX |
|---|---|---|
| Price | $6.16 | $0.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 81.0K | ★ 190.0K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,032,000.00 | N/A |
| Revenue This Year | $33.60 | $3,904.19 |
| Revenue Next Year | $30.40 | $91.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.16 | $0.40 |
| 52 Week High | $10.50 | $3.86 |
| Indicator | ECOR | NVX |
|---|---|---|
| Relative Strength Index (RSI) | 38.61 | 34.24 |
| Support Level | $5.69 | $0.40 |
| Resistance Level | $7.35 | $0.49 |
| Average True Range (ATR) | 0.66 | 0.02 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 17.60 | 11.80 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.